Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Identifying the gap between science, policies, services, and the needs of youths affected by mental disorders (2014)

  • Authors:
  • USP affiliated authors: POLANCZYK, GUILHERME VANONI - FM
  • USP Schools: FM
  • DOI: 10.1007/s00787-014-0650-8
  • Subjects: TRANSTORNOS MENTAIS (EPIDEMIOLOGIA;PREVALÊNCIA); ADOLESCÊNCIA; CRIANÇAS; TRANSTORNOS MENTAIS DIAGNOSTICADOS NA INFÂNCIA; ANTIPSICÓTICOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00787-014-0650-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    Informações sobre o Citescore
  • Título: European Child and Adolescent Psychiatry

    ISSN: 1018-8827

    Citescore - 2017: 3.05

    SJR - 2017: 1.578

    SNIP - 2017: 1.398


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2670468-10BCSEP 170 2014
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      POLANCZYK, Guilherme V. Identifying the gap between science, policies, services, and the needs of youths affected by mental disorders. European Child and Adolescent Psychiatry, Darmstadt, v. 23, p. 1119-1121, 2014. Disponível em: < doi: 10.1007/s00787-014-0650-8 > DOI: 10.1007/s00787-014-0650-8.
    • APA

      Polanczyk, G. V. (2014). Identifying the gap between science, policies, services, and the needs of youths affected by mental disorders. European Child and Adolescent Psychiatry, 23, 1119-1121. doi:10.1007/s00787-014-0650-8
    • NLM

      Polanczyk GV. Identifying the gap between science, policies, services, and the needs of youths affected by mental disorders [Internet]. European Child and Adolescent Psychiatry. 2014 ; 23 1119-1121.Available from: doi: 10.1007/s00787-014-0650-8
    • Vancouver

      Polanczyk GV. Identifying the gap between science, policies, services, and the needs of youths affected by mental disorders [Internet]. European Child and Adolescent Psychiatry. 2014 ; 23 1119-1121.Available from: doi: 10.1007/s00787-014-0650-8

    Referências citadas na obra
    Atladottir HO, Gyllenberg D, Langridge A, Sandin S, Hansen SN, Leonard H et al (2014) The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison. Eur Child Adolesc Psychiatry. doi: 10.1007/s00787-014-0553-8
    Belfer ML (2007) Critical review of world policies for mental healthcare for children and adolescents. Curr Opin Psychiatry 20(4):349–352. doi: 10.1097/YCO.0b013e3281bc0cf4
    Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS et al (2011) Grand challenges in global mental health. Nature 475(7354):27–30. doi: 10.1038/475027a
    Costello EJ, He J-P, Sampson NA, Kessler RC, Merikangas KR (2014) Services for adolescents with psychiatric disorders: 12-month data from the National Comorbidity Survey–Adolescent. Psychiatric Serv (Washington, DC) 65(3):359. doi: 10.1176/appi.ps.201100518
    Insel TR (2014) Mental disorders in childhood: shifting the focus from behavioral symptoms to neurodevelopmental trajectories. JAMA 311(17):1727–1728
    Merikangas KR, He J-P, Rapoport J, Vitiello B, Olfson M (2013) Medication use in US youth with mental disorders. JAMA Pediatrics 167(2):141. doi: 10.1001/jamapediatrics.2013.431
    Nafees B, Setyawan J, Lloyd A, Ali S, Hearn S, Sasane R et al (2014) Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries. Eur Child Adolesc Psychiatry. doi: 10.1007/s00787-013-0515-6
    Olfson M, Blanco C, Liu S-M, Wang S, Correll CU (2012) National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 69(12):1247–1256. doi: 10.1001/archgenpsychiatry.2012.647
    Olfson M, Crystal S, Huang C, Gerhard T (2010) Trends in antipsychotic drug use by very young, privately insured children. J Am Acad Child Adolesc Psychiatry 49(1):13–23. doi: 10.1016/j.jaac.2009.09.003
    Patel V, Flisher AJ, Hetrick S, McGorry P (2007) Mental health of young people: a global public-health challenge. Lancet 369(9569):1302–1313. doi: 10.1016/S0140-6736(07)60368-7
    Patel V, Kieling C, Maulik PK, Divan G (2013) Improving access to care for children with mental disorders: a global perspective. Arch Dis Child 98(5):323–327. doi: 10.1136/archdischild-2012-302079
    Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA (2014) ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. doi: 10.1093/ije/dyt261
    Pottegård A, Zoëga H, Hallas J, Damkier P (2014) Use of SSRIs among Danish children: a nationwide study. Eur Child Adolesc Psychiatry. doi: 10.1007/s00787-014-0523-1
    Pringsheim T, Lam D, Patten SB (2011) The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005–2009. J Child Adolesc Psychopharmacol 21(6):537–543. doi: 10.1089/cap.2010.0145
    Tarver J, Daley D, Lockwood J, Sayal K (2014) Are self-directed parenting interventions sufficient for externalising behaviour problems in childhood? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry. doi: 10.1007/s00787-014-0556-5
    The PERS Consortium, Glennon J, Purper-Ouakil D, Bakker M, Zuddas A, Hoekstra P et al (2013) Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. Eur Child Adolesc Psychiatry. doi: 10.1007/s00787-013-0498-3
    Visser SN, Danielson M, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM et al (2013) Trends in the parent––report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. J Am Acad Child Adolesc Psychiatry 53(1):34–46.e2. doi: 10.1016/j.jaac.2013.09.001